Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheol-In Kang

Showing results (91-100 of 275) with videos related to

Pageof 28
Sort By:
International Journal of Antimicrobial Agents|December 23, 2008
Failure of cefepime therapy in neutropenic patients with extended-spectrum beta-lactamase-producing Gram-negative bacteraemiaYu Mi Wi, Cheol-In Kang, Hae Suk Cheong, et al.
Journal of Clinical Microbiology|December 14, 2011
Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strainsCheol-In Kang, Yu Mi Wi, Mi Young Lee, et al.
Diagnostic Microbiology and Infectious Disease|April 28, 2016
Emergence of fluoroquinolone-resistant Stenotrophomonas maltophilia in blood isolates causing bacteremia: molecular epidemiology and microbiologic characteristicsMin Kyeong Cha, Cheol-In Kang, So Hyun Kim, et al.
International Journal of Antimicrobial Agents|April 3, 2014
Extended-spectrum cephalosporins and the inoculum effect in tests with CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteriaCheol-In Kang, Min Kyeong Cha, So Hyun Kim, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2017
Genetic alterations responsible for reduced susceptibility to vancomycin in community-associated MRSA strains of ST72Jin Yang Baek, Doo Ryeon Chung, Kwan Soo Ko, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 17, 2005
Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosaCheol-In Kang, Sung-Han Kim, Wan Beom Park, et al.
Journal of Clinical Microbiology|March 10, 2012
Evaluation of the GenBank, EzTaxon, and BIBI services for molecular identification of clinical blood culture isolates that were unidentifiable or misidentified by conventional methodsKyung Sun Park, Chang-Seok Ki, Cheol-In Kang, et al.
Journal of Clinical Microbiology|March 7, 2006
Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremiaDong-Min Kim, Cheol-In Kang, Chang Seop Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcomeCheol-In Kang, Sung-Han Kim, Wan Beom Park, et al.
The Korean Journal of Internal Medicine|July 1, 2011
Usefulness of C-reactive protein for evaluating clinical outcomes in cirrhotic patients with bacteremiaYoung Eun Ha, Cheol-In Kang, Eun-Jeong Joo, et al.
Pageof 28

Showing results (91-100 of 275) with videos related to

Sort By:
Pageof 28
International Journal of Antimicrobial Agents|December 23, 2008
Failure of cefepime therapy in neutropenic patients with extended-spectrum beta-lactamase-producing Gram-negative bacteraemiaYu Mi Wi, Cheol-In Kang, Hae Suk Cheong, et al.
Journal of Clinical Microbiology|December 14, 2011
Epidemiology and risk factors of community onset infections caused by extended-spectrum β-lactamase-producing Escherichia coli strainsCheol-In Kang, Yu Mi Wi, Mi Young Lee, et al.
Diagnostic Microbiology and Infectious Disease|April 28, 2016
Emergence of fluoroquinolone-resistant Stenotrophomonas maltophilia in blood isolates causing bacteremia: molecular epidemiology and microbiologic characteristicsMin Kyeong Cha, Cheol-In Kang, So Hyun Kim, et al.
International Journal of Antimicrobial Agents|April 3, 2014
Extended-spectrum cephalosporins and the inoculum effect in tests with CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli: potential clinical implications of the revised CLSI interpretive criteriaCheol-In Kang, Min Kyeong Cha, So Hyun Kim, et al.
The Journal of Antimicrobial Chemotherapy|June 9, 2017
Genetic alterations responsible for reduced susceptibility to vancomycin in community-associated MRSA strains of ST72Jin Yang Baek, Doo Ryeon Chung, Kwan Soo Ko, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 17, 2005
Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosaCheol-In Kang, Sung-Han Kim, Wan Beom Park, et al.
Journal of Clinical Microbiology|March 10, 2012
Evaluation of the GenBank, EzTaxon, and BIBI services for molecular identification of clinical blood culture isolates that were unidentifiable or misidentified by conventional methodsKyung Sun Park, Chang-Seok Ki, Cheol-In Kang, et al.
Journal of Clinical Microbiology|March 7, 2006
Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremiaDong-Min Kim, Cheol-In Kang, Chang Seop Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcomeCheol-In Kang, Sung-Han Kim, Wan Beom Park, et al.
The Korean Journal of Internal Medicine|July 1, 2011
Usefulness of C-reactive protein for evaluating clinical outcomes in cirrhotic patients with bacteremiaYoung Eun Ha, Cheol-In Kang, Eun-Jeong Joo, et al.
Pageof 28